Medtronic (www.medtronic.com), is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world.
Medtronic has been established in Ireland since 1999, having then acquired a Cardiovascular business which was established in Galway in 1982. The Galway site is now a centre of excellence for the development and manufacture of a number of the company’s key medical technologies for the treatment and management of cardiovascular and cardiac rhythm diseases.
Today over 2,500 people are employed in Ireland with most of the company’s employees working at the facility in Galway, including over 100 dedicated to research and development. In September 2013, a Customer Innovation Centre was opened providing state-of-the-art facilities for physicians and engineers to work together on developing new therapies that will improve clinical outcomes, provide economic value and increase access to quality healthcare for patients around the world.
Medtronic has a sales and shared services office in Dublin to support the Irish business.
HP Inc. creates technology that makes life better for everyone, everywhere. Through our portfolio of printers, PCs, mobile devices, solutions, and services, we engineer experiences that amaze. More information about HP Inc. is available at http://www.hp.com.
Datapac is Ireland’s leading ICT solutions provider, offering a comprehensive range of technology and service to over 6,000 private and public sector customers in Ireland. More information about Datapac is available at https://www.datapac.com
On January 1, 2013, AbbVie was founded as a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges. AbbVie now has more than 500 employees across Ireland and operates at five different locations in 3 separate parts of Ireland: Dublin, Sligo and Cork. Innovation is the cornerstone of AbbVie’s business as a global biopharmaceutical company. Our focus is on developing medicines that can provide strong clinical performance, measurable patient benefit and economic value, particularly in areas where there is significant need, such as hepatitis C, neuroscience, immunology, oncology, chronic kidney disease, and women’s health.